WASHINGTON (NewsNation Now) — The U.S. Client Product Security Fee introduced the recall of greater than 400,000 bottles of Excedrin merchandise as a result of among the bottles containing the over-the-counter drug might have a gap within the backside.
Based on the recall, the plastic bottles pose a poisoning threat, if there’s a gap, as a result of youngsters might be able to get the caplets and swallow the painkillers.
The recall covers 50, 80, 100, 152, 200, 250, and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Additional Power Caplets, Excedrin PM Headache Caplets, and Excedrin Stress Headache Caplets.
The medication had been offered nationwide and on-line from March 2018 by means of September 2020.
The recall says as a result of Excedrin comprises aspirin and acetaminophen it should be in child-resistant packaging as required by the Poison Prevention Packaging Act.
Prospects ought to instantly examine Excedrin bottles to see if there’s a gap on the backside.
If there’s a gap, customers ought to contact the producer, GSK Client Relations, for info on the way to obtain a pay as you go transport label for return to obtain a full refund.
If there isn’t a gap, the customers can preserve the over-the-counter drugs.
Prospects with questions concerning the recall can contact GSK Client Relations at 1-800-468-7746 or on-line at www.excedrin.com and click on on the “security situation” banner on the prime of the web page for extra info.